The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125734071 12573407 1 I 20160718 20160720 20160720 EXP ES-ROCHE-1797225 ROCHE PERICAY C, SERRA-ARACIL X, OCANA-ROJAS J, MORA-LOPEZ L, DOTOR E, CASALOTS A, PISA A AND SAIGI E. FURTHER EVIDENCE FOR PREOPERATIVE CHEMORADIOTHERAPY AND TRANSANAL ENDOSCOPIC SURGERY (TEM) IN T2-3S,N0,M0 RECTAL CANCER.. CLINICAL AND TRANSLATIONAL ONCOLOGY. 2016 JUL 01;18.7:666-671. 0.00 Y 0.00000 20160720 OT ES ES

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125734071 12573407 1 PS CAPECITABINE. CAPECITABINE 1 Oral U 20896 825 MG/M**2 TABLET BID
125734071 12573407 2 SS 5-FLUOROURACIL FLUOROURACIL 1 Intravenous (not otherwise specified) 300 MG/M2 A DAY, 5 DAYS A WEEK FOR 5 WEEKS U 0 300 MG/M**2 INFUSION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125734071 12573407 1 Rectal adenocarcinoma
125734071 12573407 2 Rectal adenocarcinoma

Outcome of event

Event ID CASEID OUTC COD
125734071 12573407 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125734071 12573407 Abdominal pain
125734071 12573407 Asthenia
125734071 12573407 Cystitis
125734071 12573407 Decreased appetite
125734071 12573407 Dermatitis
125734071 12573407 Diarrhoea
125734071 12573407 Mucosal inflammation
125734071 12573407 Proctalgia
125734071 12573407 Proctitis
125734071 12573407 Rectal haemorrhage
125734071 12573407 Renal failure
125734071 12573407 Thrombocytopenia
125734071 12573407 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found